title: Therapeutic Options for Immune Thrombocytopenia (ITP) During Pregnancy.
abstract: The incidence of ITP during pregnancy is low. When ITP is suspected it is necessary to perform an extended set of clinical and biological investigations in order to determine the etiology of thrombocytopenia, as the diagnosis of ITP is a process of exclusion, because there is no sensitive and specific diagnostic test so far. The treatment for ITP during pregnancy represents a challenge, being necessary in the cases selected according to the obstetrical indications, to the degree of maternal thrombocytopenia and to the extent of the hemorrhagic syndrome, as well as according to the adverse reactions of the treatment on the mother and fetus.
authors.affiliation: Emergency University Hospital, Department of Hematology, Bucarest, Romania.
authors.forename: Anca
authors.initials: A
authors.lastname: Nicolescu
authors.affiliation: Emergency University Hospital, Department of Hematology, Bucarest, Romania.
authors.forename: Ana Maria
authors.initials: AM
authors.lastname: Vladareanu
authors.affiliation: Emergency University Hospital, Department of Hematology, Bucarest, Romania.
authors.forename: Irina
authors.initials: I
authors.lastname: Voican
authors.affiliation: Emergency University Hospital, Department of Hematology, Bucarest, Romania.
authors.forename: Minodora
authors.initials: M
authors.lastname: Onisai
authors.affiliation: Elias Emergency University Hospital, Department of Obstetrics-Gynecology, Bucharest, Romania.
authors.forename: Radu
authors.initials: R
authors.lastname: Vladareanu
keywords: Immune thrombocytopenia; corticotherapy; hemorrhage; pregnancy